Literature DB >> 6457076

Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study.

M J Polley, L L Leung, F Y Clark, R L Nachman.   

Abstract

The topographic relationships of platelet membrane glycoprotein IIb and glycoprotein IIIa have been studied in stimulated and unstimulated human platelets using immunoelectron microscopy. An indirect approach with ferritin-conjugated goat anti-rabbit gamma-globulin was used to localize the rabbit antibody to glycoprotein IIIa. The second ultrastructural label was keyhole limpet hemocyanin conjugated directly to antibody to glycoprotein IIb. Using the double labels, it was demonstrated that glycoprotein IIb and glycoprotein IIIa were distributed randomly in the unstimulated platelet membrane. After platelet stimulation with thrombin, large clusters of glycoprotein IIb-glycoprotein IIIa complexes were formed. No complex formation between glycoprotein Ib and glycoprotein IIb was observed in control experiments. These observations suggest that thrombin stimulation initiates the specific glycoprotein IIb-glycoprotein IIIa macromolecular complex formation on the platelet surface, which may act as the active fibrinogen-binding site required for normal platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457076      PMCID: PMC2186487          DOI: 10.1084/jem.154.4.1058

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

Review 1.  The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets.

Authors:  A T Nurden; J P Caen
Journal:  Semin Hematol       Date:  1979-07       Impact factor: 3.851

2.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  An ultrastructural staining method for enhancing the size and electron opacity of ferritin in thin sections.

Authors:  S K Ainsworth; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1972-03       Impact factor: 2.479

4.  Exposure of platelet fibrinogen receptors by ADP and epinephrine.

Authors:  J S Bennett; G Vilaire
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

5.  Immunoinhibition of ristocetin-induced platelet aggregation.

Authors:  R L Nachman; E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function.

Authors:  S Levy-Toledano; G Tobelem; C Legrand; R Bredoux; L Degos; A Nurden; J P Caen
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

7.  Correlation between fibrinogen binding to human platelets and platelet aggregability.

Authors:  E I Peerschke; M B Zucker; R A Grant; J J Egan; M M Johnson
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

8.  Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome.

Authors:  I Hagen; A Nurden; O J Bjerrum; N O Solum; J Caen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

9.  Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties.

Authors:  M J Karnovsky; E R Unanue; M Leventhal
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

10.  The human complement system in thrombin-mediated platelet function.

Authors:  M J Polley; R Nachman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  16 in total

1.  Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.

Authors:  M E Hensler; M Frojmovic; R G Taylor; R R Hantgan; J C Lewis
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation.

Authors:  S C Watkins; V Raso; H S Slayter
Journal:  Histochem J       Date:  1990-09

3.  Alterations of wheat-germ agglutinin binding pattern on cell surface of blood platelets after thrombin stimulation.

Authors:  T Daimon; I S Sano-Martins
Journal:  Histochemistry       Date:  1989

4.  Freeze-fracture cytochemistry of wheat germ agglutinin and concanavalin A receptors on the plasma membrane of normal, Bernard-Soulier, and thrombasthenic platelets.

Authors:  J Chevalier; J P Caen; P Pinto da Silva
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Glycoprotein Ib distribution on the surface of platelets in resting and activation states: an electron microscope study.

Authors:  H Suzuki; N Yamamoto; K Tanoue; H Yamazaki
Journal:  Histochem J       Date:  1987-03

6.  Complex formation of platelet thrombospondin with fibrinogen.

Authors:  L L Leung; R L Nachman
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

7.  Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.

Authors:  R L Nachman; L L Leung
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

8.  The mechanism of kindlin-mediated activation of integrin αIIbβ3.

Authors:  Feng Ye; Brian G Petrich; Praju Anekal; Craig T Lefort; Ana Kasirer-Friede; Sanford J Shattil; Raphael Ruppert; Markus Moser; Reinhard Fässler; Mark H Ginsberg
Journal:  Curr Biol       Date:  2013-11-07       Impact factor: 10.834

9.  Morphological evidence for the association of plasma membrane glycoprotein IIb/IIIa with the membrane skeleton in human platelets.

Authors:  H Suzuki; K Tanoue; H Yamazaki
Journal:  Histochemistry       Date:  1991

10.  Fibrinogen and glycoprotein IIb/IIIa localization during platelet adhesion. Localization to the granulomere and at sites of platelet interaction.

Authors:  J C Lewis; R R Hantgan; S C Stevenson; T Thornburg; N Kieffer; J Guichard; J Breton-Gorius
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.